PRLD vs TPR · rev $6.5M vs P/E 46, rev $8.00B
Prelude Therapeutics Inc (PRLD) versus Tapestry Inc (TPR) — a side-by-side from cached financials, not a winner call.
Prelude Therapeutics Inc (PRLD) is a biotechnology company listed on NASDAQ.
Tapestry Inc (TPR) is a luxury goods company listed on NYSE.
Latest reported PRLD revenue for 2025-09-30 was $6.5M. Net income was -$83.0M. Revenue was up 116.7% from 2024-09-30 to 2025-09-30. PRLD currently screens at market cap $346.5M.
Latest reported TPR revenue for 2026-06-27 was $8.00B. Net income was $1.53B. Revenue was up 14.2% from 2025-06-28 to 2026-06-27. TPR currently screens at market cap $30.81B and trailing P/E 46.3.
PRLD currently screens at market cap $346.5M. TPR currently screens at market cap $30.81B and trailing P/E 46.3.
Not investment advice. Open the PRLD and TPR stock pages for the full models.
Not investment advice.